Cardioprotective effects of diazoxide on myocardial ischemia/reperfusion injury in rats

Abstract

In order to study the cardioprotective effects of diazoxide on the myocardial ischemia/reperfusion injury of rats and mechanisms, the healthy SD rats were randomly divided into 2 groups: the rats in the experimental group were injected with diazoxide for preconditioning with the dosage of 12.5 mg/kg through the right femoral vein and those in the control group was only administered with the equal volume of media. After 10 min, a left thoracotomy was performed and the left anterior descending branch was occluded for 2 h. Two h later, the left anterior descending branch was reperfused for 2 h and then the heart was quickly excised to be used for measurement of MDA, SOD and the infarct size, in situ cell apoptosis detection and observation of the cell ultrastructure by electron microscopy. The results showed that as compared with the control group, MDA, the infarct size and cell apoptosis in the experimental group were greatly reduced (P<0.05). And the cell ultrastructure was obviously improved. But the activity of SOD had no change (P>0.05). It was concluded that diazoxide could protect the rats from myocardial ischemia/reperfusion injury, which might be contributed to the reduction of lipid peroxidation and cell apoptosis.

Keywords

diazoxide / cardioprotection / ischemia/reperfusion injury / apoptosis / rat

References

[1] MurphyE.. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res, 2004, 94: 7-16

[2] GarlidK. D., PaucekP., Yarov-YarovoyV., et al.. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K⁺ channels. Circ Res, 1997, 81: 1072-1082

[3] PratzJ., MondotS., MontierF., et al.. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, phasma rennin activity and blood pressure in rats. J Pharmacol Exp Ther, 1991, 258(1): 216-222

[4] Dos SantosP., KowaltowskiA. J., LaclauM. N., et al.. Mechanisms by which opening the mitochondrial ATP-sensitive K⁺ channel protects the ischemic heart. Am J Physiol Heart Circ Physiol, 2002, 283: H284-H295

[5] OldenburgO., QinQ., SharmaA. R., et al.. Acetyleholine leads to free radical production dependent on K_ATP channels, Gi proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res, 2002, 55: 544-552

[6] BainesC. P., ZhangJ., WangG. W., et al.. Mitochondrial PKCc and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCc-MAPK interactions and differential MAPK activation in PKCc-induced cardioprotection. Circ Res, 2002, 90: 390-397

[7] WakaharaN., KatohH., YaguchiY., et al.. Difference in the cardioprotective mechanisms between ischemic preconditioning and pharmacological preconditioning by diazoxide in rat hearts. Circ J, 2004, 68(2): 152-162

[8] XuZ., JiX., BoysenP. G.. Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol, 2004, 286(4): H1433-H1440

[9] LiemD. A., GhoC. C., GhoB. C., et al.. The tyrosine phosphatase inhibitor bis (maltolato)-oxovanadium attenuates myocardial reperfusion injury by opening K⁺_ATP channels. JPET, 2004, 309(3): 1256-1262

[10] EftingF., RensingB., WigmanJ., et al.. Role of apoptosis in reperfusion injury. Cardiovasc Res, 2004, 61(3): 414-426

[11] KinH., ZhaoZ. Q., SunH. Y., et al.. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res, 2004, 62(1): 74-785